196 related articles for article (PubMed ID: 18212552)
41. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal.
Saeed S; Keehn CA; Morgan MB
J Cutan Pathol; 2004 Jul; 31(6):419-30. PubMed ID: 15186430
[TBL] [Abstract][Full Text] [Related]
42. Finger skin metastasis from hepatocellular carcinoma: a case report.
Kim JI; Song CH; Gong HS
Hand Surg; 2012; 17(1):131-4. PubMed ID: 22351551
[TBL] [Abstract][Full Text] [Related]
43. Atypical presentation of hepatocellular carcinoma: a mass on the left thoracic wall.
Coban S; Yüksel O; Köklü S; Ceyhan K; Baykara M; Dökmeci A
BMC Cancer; 2004 Dec; 4():89. PubMed ID: 15574203
[TBL] [Abstract][Full Text] [Related]
44. Skull metastasis from hepatocellular carcinoma.
Hsieh CT; Sun JM; Tsai WC; Tsai TH; Chiang YH; Liu MY
Acta Neurochir (Wien); 2007 Feb; 149(2):185-90. PubMed ID: 17180305
[TBL] [Abstract][Full Text] [Related]
45. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
[TBL] [Abstract][Full Text] [Related]
46. Digital acrometastases as first sign of hepatocellular carcinoma.
Rauf MS; Motta L; Connolly C
Scott Med J; 2012 Nov; 57(4):247. PubMed ID: 23002154
[TBL] [Abstract][Full Text] [Related]
47. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
Lu Y; Wu LQ; Li CS; Wang SG; Han B
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
[TBL] [Abstract][Full Text] [Related]
48. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver.
Gokden M; Shinde A
Diagn Cytopathol; 2005 Sep; 33(3):166-72. PubMed ID: 16078249
[TBL] [Abstract][Full Text] [Related]
49. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
Yoder M; Zimmerman RL; Bibbo M
Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892
[TBL] [Abstract][Full Text] [Related]
50. Cutaneous metastasis from hepatocellular carcinoma as the first clinical sign.
Amador A; Monforte NG; Bejarano N; Martí J; Artigau E; Navarro S; Fuster J
J Hepatobiliary Pancreat Surg; 2007; 14(3):328-30. PubMed ID: 17520212
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous metastasis from hepatocellular carcinoma.
Syrios J; Logothetis M; Tountas H; Grivas A; Lianos E; Athanasiou AE
J BUON; 2012; 17(4):797-8. PubMed ID: 23335546
[No Abstract] [Full Text] [Related]
52. Metastasis of hepatocellular carcinoma to spleen and small intestine.
Iwaki K; Ohta M; Ishio T; Kai S; Iwashita Y; Shibata K; Himeno K; Seike M; Fujioka T; Kitano S
J Hepatobiliary Pancreat Surg; 2008; 15(2):213-9. PubMed ID: 18392718
[TBL] [Abstract][Full Text] [Related]
53. [A case of hepatocellular carcinoma with metastasis to gingival mucosa].
Choi SJ; Kim YS; Kim NR; Jeong SW; Lee SH; Jeong JS; Ryu KH; Cha SW; Hong SJ; Ryu CB; Moon JH; Kim YS; Lee MS; Shim CS; Kim BS; Kwon KW; Kim BY
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):495-9. PubMed ID: 12506256
[TBL] [Abstract][Full Text] [Related]
54. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
55. [Metastatic hepatocellular carcinoma: right atrial tumor as primary clinical manifestation. Case report].
Afonso DV; Laranjeira A; Galrinho A; Fragata J
Rev Port Cir Cardiotorac Vasc; 2008; 15(2):79-81. PubMed ID: 18923776
[TBL] [Abstract][Full Text] [Related]
56. Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary.
Shah S; Gupta S; Shet T; Maheshwari A; Wuntkal R; Mohandas KM
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):306-7. PubMed ID: 15908336
[TBL] [Abstract][Full Text] [Related]
57. [An atypical bone metastasis of hepatocellular carcinoma: case report and review of the literature].
Fontana T; Siciliano M; Franceschelli A; Annicchiarico BE; Rossi P; Bigotti G; Bombardieri G
Clin Ter; 2004 Oct; 155(10):447-51. PubMed ID: 15702658
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the CD34 and CD10 immunostains using a two-color staining protocol in liver fine-needle aspiration biopsies.
Zimmerman RL; Logani S; Baloch Z
Diagn Cytopathol; 2005 Feb; 32(2):88-91. PubMed ID: 15637673
[TBL] [Abstract][Full Text] [Related]
59. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
Tátrai P; Somorácz A; Batmunkh E; Schirmacher P; Kiss A; Schaff Z; Nagy P; Kovalszky I
Am J Surg Pathol; 2009 Jun; 33(6):874-85. PubMed ID: 19194276
[TBL] [Abstract][Full Text] [Related]
60. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
